Immunoassay-Compatible Inactivation of SARS-CoV-2 in Plasma Samples for Enhanced Handling Safety

[Image: see text] Severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2) inactivation is an important step toward enhanced biosafety in testing facilities and affords a reduction in the biocontainment level necessary for handling virus-positive biological specimens. Virus inactivation methods...

Descripción completa

Detalles Bibliográficos
Autores principales: Liew, Oi Wah, Fanusi, Felic, Ng, Jessica Yan Xia, Ahidjo, Bintou Ahmadou, Ling, Samantha Shi Min, Lilyanna, Shera, Chong, Jenny Pek Ching, Lim, Angeline Eng Siew, Lim, Wei Zheng, Ravindran, Sindhu, Chu, Justin Jang Hann, Lim, Shir Lynn, Richards, Arthur Mark
Formato: Online Artículo Texto
Lenguaje:English
Publicado: American Chemical Society 2022
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9301769/
https://www.ncbi.nlm.nih.gov/pubmed/35903176
http://dx.doi.org/10.1021/acsomega.2c02585

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9301769/
https://www.ncbi.nlm.nih.gov/pubmed/35903176
http://dx.doi.org/10.1021/acsomega.2c02585

Ejemplares similares